Alpha Teknova (NASDAQ:TKNO) Upgraded by Roth Capital to Strong-Buy Rating

Roth Capital upgraded shares of Alpha Teknova (NASDAQ:TKNO) to a strong-buy rating in a research note released on Wednesday,Zacks.com reports.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alpha Teknova in a research report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $7.00.

Alpha Teknova Trading Up 1.6%

TKNO stock opened at $5.61 on Wednesday. The company has a debt-to-equity ratio of 0.20, a current ratio of 4.59 and a quick ratio of 3.60. The company has a fifty day moving average price of $5.17 and a two-hundred day moving average price of $3.71. Alpha Teknova has a one year low of $1.91 and a one year high of $6.68. The stock has a market cap of $300.75 million, a price-to-earnings ratio of -17.53 and a beta of 0.64.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.02. The company had revenue of $12.19 million for the quarter, compared to analyst estimates of $10.95 million. Alpha Teknova had a negative net margin of 41.07% and a negative return on equity of 24.32%.

Institutional Investors Weigh In On Alpha Teknova

Large investors have recently added to or reduced their stakes in the stock. Roubaix Capital LLC increased its stake in Alpha Teknova by 88.5% during the 1st quarter. Roubaix Capital LLC now owns 1,882,355 shares of the company’s stock worth $5,440,000 after acquiring an additional 883,823 shares during the period. Balyasny Asset Management L.P. increased its position in shares of Alpha Teknova by 19.5% in the second quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock worth $4,912,000 after purchasing an additional 163,526 shares during the period. Conestoga Capital Advisors LLC increased its position in shares of Alpha Teknova by 2.6% in the fourth quarter. Conestoga Capital Advisors LLC now owns 317,084 shares of the company’s stock worth $1,205,000 after purchasing an additional 8,145 shares during the period. Geode Capital Management LLC raised its stake in Alpha Teknova by 64.4% in the second quarter. Geode Capital Management LLC now owns 298,850 shares of the company’s stock valued at $1,468,000 after purchasing an additional 117,016 shares in the last quarter. Finally, Royce & Associates LP bought a new stake in Alpha Teknova during the fourth quarter worth about $1,116,000. Institutional investors and hedge funds own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.